Literature DB >> 18561645

Quantifying the interplay effect in prostate IMRT delivery using a convolution-based method.

Haisen S Li1, Indrin J Chetty, Timothy D Solberg.   

Abstract

The authors present a segment-based convolution method to account for the interplay effect between intrafraction organ motion and the multileaf collimator position for each particular segment in intensity modulated radiation therapy (IMRT) delivered in a step-and-shoot manner. In this method, the static dose distribution attributed to each segment is convolved with the probability density function (PDF) of motion during delivery of the segment, whereas in the conventional convolution method ("average-based convolution"), the static dose distribution is convolved with the PDF averaged over an entire fraction, an entire treatment course, or even an entire patient population. In the case of IMRT delivered in a step-and-shoot manner, the average-based convolution method assumes that in each segment the target volume experiences the same motion pattern (PDF) as that of population. In the segment-based convolution method, the dose during each segment is calculated by convolving the static dose with the motion PDF specific to that segment, allowing both intrafraction motion and the interplay effect to be accounted for in the dose calculation. Intrafraction prostate motion data from a population of 35 patients tracked using the Calypso system (Calypso Medical Technologies, Inc., Seattle, WA) was used to generate motion PDFs. These were then convolved with dose distributions from clinical prostate IMRT plans. For a single segment with a small number of monitor units, the interplay effect introduced errors of up to 25.9% in the mean CTV dose compared against the planned dose evaluated by using the PDF of the entire fraction. In contrast, the interplay effect reduced the minimum CTV dose by 4.4%, and the CTV generalized equivalent uniform dose by 1.3%, in single fraction plans. For entire treatment courses delivered in either a hypofractionated (five fractions) or conventional (> 30 fractions) regimen, the discrepancy in total dose due to interplay effect was negligible.

Entities:  

Mesh:

Year:  2008        PMID: 18561645      PMCID: PMC2673640          DOI: 10.1118/1.2897972

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  21 in total

1.  Evaluation of the validity of a convolution method for incorporating tumour movement and set-up variations into the radiotherapy treatment planning system.

Authors:  S D McCarter; W A Beckham
Journal:  Phys Med Biol       Date:  2000-04       Impact factor: 3.609

2.  Inverse planning incorporating organ motion.

Authors:  J G Li; L Xing
Journal:  Med Phys       Date:  2000-07       Impact factor: 4.071

3.  Effects of intra-fraction motion on IMRT dose delivery: statistical analysis and simulation.

Authors:  Thomas Bortfeld; Kimmo Jokivarsi; Michael Goitein; Jong Kung; Steve B Jiang
Journal:  Phys Med Biol       Date:  2002-07-07       Impact factor: 3.609

4.  An experimental investigation on intra-fractional organ motion effects in lung IMRT treatments.

Authors:  Steve B Jiang; Cynthia Pope; Khaled M Al Jarrah; Jong H Kung; Thomas Bortfeld; George T Y Chen
Journal:  Phys Med Biol       Date:  2003-06-21       Impact factor: 3.609

5.  The effects of intra-fraction organ motion on the delivery of intensity-modulated field with a multileaf collimator.

Authors:  Chen-Shou Chui; Ellen Yorke; Linda Hong
Journal:  Med Phys       Date:  2003-07       Impact factor: 4.071

6.  A fluence convolution method to account for respiratory motion in three-dimensional dose calculations of the liver: a Monte Carlo study.

Authors:  Indrin J Chetty; Mihaela Rosu; Neelam Tyagi; Lon H Marsh; Daniel L McShan; James M Balter; Benedick A Fraass; Randall K Ten Haken
Journal:  Med Phys       Date:  2003-07       Impact factor: 4.071

7.  Optimization of intensity-modulated radiotherapy plans based on the equivalent uniform dose.

Authors:  Qiuwen Wu; Radhe Mohan; Andrzej Niemierko; Rupert Schmidt-Ullrich
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-01-01       Impact factor: 7.038

8.  Quantifying the effect of intrafraction motion during breast IMRT planning and dose delivery.

Authors:  R George; P J Keall; V R Kini; S S Vedam; J V Siebers; Q Wu; M H Lauterbach; D W Arthur; R Mohan
Journal:  Med Phys       Date:  2003-04       Impact factor: 4.071

9.  A method of calculating a lung clinical target volume DVH for IMRT with intrafractional motion.

Authors:  J H Kung; P Zygmanski; N Choi; G T Y Chen
Journal:  Med Phys       Date:  2003-06       Impact factor: 4.071

10.  Limitations of a convolution method for modeling geometric uncertainties in radiation therapy. I. The effect of shift invariance.

Authors:  Tim Craig; Jerry Battista; Jake Van Dyk
Journal:  Med Phys       Date:  2003-08       Impact factor: 4.071

View more
  10 in total

1.  Dosimetric effect of intrafraction motion and residual setup error for hypofractionated prostate intensity-modulated radiotherapy with online cone beam computed tomography image guidance.

Authors:  Justus Adamson; Qiuwen Wu; Di Yan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-06-18       Impact factor: 7.038

Review 2.  Robustness Analysis for External Beam Radiation Therapy Treatment Plans: Describing Uncertainty Scenarios and Reporting Their Dosimetric Consequences.

Authors:  Adam D Yock; Radhe Mohan; Stella Flampouri; Walter Bosch; Paige A Taylor; David Gladstone; Siyong Kim; Jason Sohn; Robert Wallace; Ying Xiao; Jeff Buchsbaum
Journal:  Pract Radiat Oncol       Date:  2018-12-15

3.  Prostate intrafraction motion assessed by simultaneous kilovoltage fluoroscopy at megavoltage delivery I: clinical observations and pattern analysis.

Authors:  Justus Adamson; Qiuwen Wu
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-06-25       Impact factor: 7.038

4.  Determination of action thresholds for electromagnetic tracking system-guided hypofractionated prostate radiotherapy using volumetric modulated arc therapy.

Authors:  Pengpeng Zhang; Dennis Mah; Laura Happersett; Brett Cox; Margie Hunt; Gig Mageras
Journal:  Med Phys       Date:  2011-07       Impact factor: 4.071

5.  The dosimetric effect of intrafraction prostate motion on step-and-shoot intensity-modulated radiation therapy plans: magnitude, correlation with motion parameters, and comparison with helical tomotherapy plans.

Authors:  Katja M Langen; Bhavin Chauhan; Jeffrey V Siebers; Joseph Moore; Patrick A Kupelian
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-04-06       Impact factor: 7.038

6.  A method of dose reconstruction for moving targets compatible with dynamic treatments.

Authors:  Per Rugaard Poulsen; Mai Lykkegaard Schmidt; Paul Keall; Esben Schjodt Worm; Walther Fledelius; Lone Hoffmann
Journal:  Med Phys       Date:  2012-10       Impact factor: 4.071

7.  Assessing the dosimetric impact of real-time prostate motion during volumetric modulated arc therapy.

Authors:  Juan Diego Azcona; Lei Xing; Xin Chen; Karl Bush; Ruijiang Li
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-04-01       Impact factor: 7.038

8.  Evaluation of the radiobiological gamma index with motion interplay in tangential IMRT breast treatment.

Authors:  Iori Sumida; Hajime Yamaguchi; Indra J Das; Hisao Kizaki; Keiko Aboshi; Mari Tsujii; Yuji Yamada; Kiesuke Tamari; Osamu Suzuki; Yuji Seo; Fumiaki Isohashi; Yasuo Yoshioka; Kazuhiko Ogawa
Journal:  J Radiat Res       Date:  2016-08-16       Impact factor: 2.724

9.  A two-point scheme for optimal breast IMRT treatment planning.

Authors:  Weiguang Yao
Journal:  J Appl Clin Med Phys       Date:  2013-11-04       Impact factor: 2.102

10.  Robust plan optimization using edge-enhanced intensity for intrafraction organ deformation in prostate intensity-modulated radiation therapy.

Authors:  Iori Sumida; Hajime Yamaguchi; Indra J Das; Yusuke Anetai; Hisao Kizaki; Keiko Aboshi; Mari Tsujii; Yuji Yamada; Keisuke Tamari; Yuji Seo; Fumiaki Isohashi; Yasuo Yoshioka; Kazuhiko Ogawa
Journal:  PLoS One       Date:  2017-03-10       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.